- Incyte Launches #MyMPNChallenge to Inspire the Myeloproliferative Neoplasm (MPN) Community During Blood Cancer Awareness Month
- Data from Incyte’s Oncology Portfolio to be Featured at the 2019 ESMO Congress
- Incyte to Present at Upcoming Investor Conferences
- Incyte Reports 2019 Second Quarter Financial Results and Provides Updates on Key Clinical Programs
- Incyte to Report Second Quarter Financial Results
- Incyte and Zai Lab Announce Collaboration and License Agreement for INCMGA0012 in Greater China
Incyte Corp (INCY:NSQ) closed at 76.43, -14.41% below its 52-week high of 89.30, set on Jun 24, 2019.
57.00Dec 24 201889.30Jun 24 2019
Markit short selling activity
|Market cap||16.44bn USD|
|EPS (TTM)||1.41 |
Data delayed at least 15 minutes, as of Sep 13 2019 21:00 BST.